Carney Patricia A, Abraham Linn A, Miglioretti Diana L, Yabroff K Robin, Sickles Edward A, Buist Diana S M, Kasales Claudia J, Geller Berta M, Rosenberg Robert D, Dignan Mark B, Weaver Donald L, Kerlikowske Karla
Norris Cotton Cancer Center, Dartmouth Medical School, Lebanon, NH 03756, USA.
AJR Am J Roentgenol. 2007 Feb;188(2):385-92. doi: 10.2214/AJR.05.1718.
The purpose of this study was to characterize the type and frequency of diagnostic evaluations after screening mammography and to summarize their association with the likelihood of biopsy and subsequent breast cancer diagnosis.
The data source was 584,470 women with no previous breast cancer from six states in the Breast Cancer Surveillance Consortium. In this observational study, we linked data from 1,207,631 routine screening mammograms performed between January 1, 1996, and December 31, 2002, to data on additional imaging, interventional procedures, and biopsy outcome (benign or malignant). Additional examinations were categorized into diagnostic mammography, sonography, or both. Events were further subdivided by whether they were performed on the same day as the screening examination and whether patients reported breast symptoms. Logistic regression analysis was used to examine the association between additional evaluation performed and the likelihood of biopsy and the likelihood of subsequent breast cancer diagnosis after adjustment for patient and screening mammographic characteristics.
Most (92%) of the screening examinations did not include additional imaging. The probability of biopsy ranged from 0.4% for examinations with no follow-up to 20.1% for those with diagnostic mammography and sonography on the same day as screening among women without symptoms and from 2.1% for those with no follow-up to 18.9% for those with diagnostic mammography and sonography on a day different from screening among women with symptoms. Thirty percent of women without symptoms who underwent biopsy had cancer, whereas 27.1% of women with symptoms who underwent biopsy had cancer. Women who underwent biopsy after screening mammography with diagnostic mammography and sonography on the same day had the highest probability of breast cancer (37.6% among women without symptoms, 36.4% among women with symptoms), whereas those who underwent only sonography performed at a later date had the lowest probability of breast cancer (11.9% among women without symptoms, 17.1% among women with symptoms).
Women who undergo screening mammography followed by diagnostic mammography and sonography have a high probability of undergoing biopsy and having the biopsy result of breast cancer when follow-up imaging is performed on the same day as screening mammography whether or not breast symptoms are present. Biopsy performed after sonography in the absence of diagnostic mammography had a low yield of breast cancer.
本研究旨在描述乳腺钼靶筛查后诊断性评估的类型和频率,并总结其与活检可能性及后续乳腺癌诊断的相关性。
数据来源为乳腺癌监测联盟中六个州的584,470名既往无乳腺癌的女性。在这项观察性研究中,我们将1996年1月1日至2002年12月31日期间进行的1,207,631例常规乳腺钼靶筛查数据与额外影像学检查、介入操作及活检结果(良性或恶性)的数据相链接。额外检查分为诊断性乳腺钼靶、超声或两者皆有。事件根据是否与筛查检查在同一天进行以及患者是否报告乳腺症状进一步细分。采用逻辑回归分析,在对患者和乳腺钼靶筛查特征进行调整后,检验额外评估与活检可能性以及后续乳腺癌诊断可能性之间的关联。
大多数(92%)的筛查检查未进行额外影像学检查。在无症状女性中,未进行后续检查的检查活检概率为0.4%,与筛查同一天进行诊断性乳腺钼靶和超声检查的检查活检概率为20.1%;在有症状女性中,未进行后续检查的检查活检概率为2.1%,与筛查不同一天进行诊断性乳腺钼靶和超声检查的检查活检概率为18.9%。接受活检的无症状女性中有30%患癌,有症状女性中有27.1%患癌。在乳腺钼靶筛查后同一天进行诊断性乳腺钼靶和超声检查后接受活检的女性患乳腺癌的概率最高(无症状女性中为37.6%,有症状女性中为36.4%),而仅在之后进行超声检查的女性患乳腺癌的概率最低(无症状女性中为11.9%,有症状女性中为17.1%)。
无论有无乳腺症状,在乳腺钼靶筛查后同一天进行后续影像学检查,随后进行诊断性乳腺钼靶和超声检查的女性接受活检以及活检结果为乳腺癌的概率较高。在未进行诊断性乳腺钼靶检查的情况下仅进行超声检查后进行活检,乳腺癌检出率较低。